Author Description

Introduction -- The U.s. Ethical Pharmaceutical Industry -- Disequilibrium, Monopoly Power, And The Rate Of Return -- The Internal Rate Of Return Of The U.s. Ethical Pharmaceutical Industry -- The Cost Of Capital In The U.s. Ethical Pharmaceutical Industry -- Competition In The U.s. Ethical Pharmaceutical Industry -- The Incentives For Drug Innovation Meir Statman. Includes Bibliographical References.